Company Filing History:
Years Active: 2016-2024
Title: The Innovative Contributions of Eric Stava
Introduction
Eric Stava is a prominent inventor based in San Diego, California. He has made significant contributions to the field of polynucleotide sequencing, holding a total of six patents. His work focuses on advancing methods and compositions that enhance the understanding and manipulation of genetic materials.
Latest Patents
Among his latest patents is a method for reagent exchange in an instrument. This method involves flowing an incorporation reagent through a reagent management system and a flow cell, where a first polynucleotide is positioned. The incorporation reagent adds a first base onto a sequence of bases, which includes a second polynucleotide complementary to the first. An image of an identification signal emanating from the first base is captured after the addition. Additionally, a cleavage reagent is used to remove a first terminator from the first base, allowing for subsequent bases to be added. Another notable patent involves methods and compositions for characterizing a target polynucleotide, utilizing fractional translocation steps of the target's translocation through a pore.
Career Highlights
Eric Stava has worked with notable organizations such as Illumina Corporation and the Wisconsin Alumni Research Foundation. His experience in these companies has allowed him to develop and refine his innovative techniques in the field of genetic research.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including Jens H. Gundlach and Jeffrey G. Mandell. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eric Stava's contributions to the field of polynucleotide sequencing are noteworthy and impactful. His innovative patents and collaborations reflect his dedication to advancing genetic research. His work continues to influence the scientific community and pave the way for future innovations.